Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-07

Clinical Trial Update: Examination of ACT Implementation in a Vivax / Falciparum Co-endemic Area [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating implementation of artemisinin-based combination therapy for malaria in vivax- and falciparum-endemic areas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemisinin-based combination therapy (ACT)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria, Fever | Phase 4 | Status: COMPLETED